Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-25-004509

SVP, CHIEF TECHNICAL OFFICER gave up 15,292 shares (to pay taxes)

  • SVP, CHIEF TECHNICAL OFFICER acquired 34,652 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER 2025-02-15 Option exercise +3,386 177,142 D
LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER 2025-02-15 Shares withheld for taxes −1,304 $58.29 $76,010 175,838 D
LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER 2025-02-16 Option exercise +20,891 196,729 D
LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER 2025-02-16 Shares withheld for taxes −8,721 $58.29 $508,347 188,008 D
LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER 2025-02-16 Option exercise +6,112 194,120 D
LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER 2025-02-16 Shares withheld for taxes −3,103 $58.29 $180,874 191,017 D
LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER 2025-02-16 Option exercise +4,263 195,280 D
LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER 2025-02-16 Shares withheld for taxes −2,164 $58.29 $126,140 193,116 D
Derivatives
LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER 2025-02-15 Option exercise · Restricted Stock Units −3,386 0 D
LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER 2025-02-16 Option exercise · Performance Stock Units −20,891 0 D
LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER 2025-02-16 Option exercise · Restricted Stock Units −6,112 6,112 D
LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER 2025-02-16 Option exercise · Restricted Stock Units −4,263 8,526 D
Loading xslF345X05/form4-02182025_110228.xml…